News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

With Peptor Ltd. Acquisition Complete, DeveloGen AG Gets $22.8 Million Round Three


10/19/2005 5:11:23 PM

DeveloGen, a German biotech start-up focused on treatments for metabolic disease, has completed its acquisition of Israeli drug discovery company Peptor, and the merged company has raised EUR19 million ($22.8 million) in a still-open round.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES